Publication & Citation Trends
Publications
0 total
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma OA
Cited by 36
Semantic Scholar
Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma OA
Cited by 14
Semantic Scholar
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma OA
Cited by 24
Semantic Scholar
Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma
Cited by 43
Semantic Scholar
Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multipeptide vaccine for resected stages IIIC and IV melanoma.
Cited by 12
Semantic Scholar
Phase II trial of sagopilone (ZK-EPO), a novel synthetic epothilone, with significant activity in metastatic melanoma.
Cited by 7
Semantic Scholar
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. OA
Cited by 170
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(4)
Multiple Myeloma Research and Treatments
(4)
HER2/EGFR in Cancer Research
(3)
CAR-T cell therapy research
(3)
Melanoma and MAPK Pathways
(3)
Affiliations
Cedars-Sinai Medical Center
University of California, San Francisco
University of South Florida
Moffitt Cancer Center
USA Mitchell Cancer Institute